Rani Therapeutics Holdings, Inc.
RANI
$0.84
-$0.03-3.73%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 53.39M | 43.40M | 49.71M | 4.14M | 10.22M |
| Total Receivables | 2.24M | 2.11M | 2.04M | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 690.00K | 1.38M | 2.94M | 311.00K | 357.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 200.00K | 200.00K | 200.00K | 500.00K | 500.00K |
| Total Current Assets | 56.52M | 47.09M | 53.32M | 4.96M | 11.07M |
|
|
|||||
| Total Current Assets | 56.52M | 47.09M | 53.32M | 4.96M | 11.07M |
| Net Property, Plant & Equipment | 4.07M | 4.54M | 5.05M | 4.94M | 5.53M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 246.00K | 246.00K | 246.00K | 245.00K | 293.00K |
| Total Assets | 60.84M | 51.88M | 58.62M | 10.14M | 16.90M |
|
|
|||||
| Total Accounts Payable | 1.05M | 858.00K | 309.00K | 2.47M | 1.80M |
| Total Accrued Expenses | 3.07M | 4.61M | 7.84M | 1.96M | 2.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.33M | 1.46M | 1.59M | 14.59M | 16.19M |
| Total Finance Division Other Current Liabilities | 5.19M | 6.93M | 13.71M | 133.00K | 90.00K |
| Total Other Current Liabilities | 5.19M | 6.93M | 13.71M | 133.00K | 90.00K |
| Total Current Liabilities | 10.64M | 13.86M | 12.67M | 19.14M | 20.62M |
|
|
|||||
| Total Current Liabilities | 10.64M | 13.86M | 12.67M | 19.14M | 20.62M |
| Long-Term Debt | -- | -- | -- | -- | 2.23M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.22M | 2.48M | 2.73M | 2.97M | 3.20M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 1.71M | -- | -- |
| Total Liabilities | 12.86M | 16.34M | 17.11M | 22.11M | 26.05M |
|
|
|||||
| Common Stock & APIC | 186.27M | 168.03M | 165.59M | 114.41M | 111.29M |
| Retained Earnings | -147.00M | -139.61M | -132.58M | -122.28M | -116.86M |
| Treasury Stock & Other | -30.00K | -8.00K | 1.00K | 3.00K | 3.00K |
| Total Common Equity | 39.23M | 28.41M | 33.01M | -7.86M | -5.58M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 39.23M | 28.41M | 33.01M | -7.86M | -5.58M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 8.75M | 7.14M | 8.50M | -4.11M | -3.58M |
| Total Equity | 47.99M | 35.54M | 41.51M | -11.97M | -9.15M |
|
|
|||||